Somerset pemetrexed injection recalled for lack of sterility
A recall covers 12,000 vials of Pemetrexed for Injection, 100 mg per vial, sold nationwide in the USA. The notice cites a lack of sterility assurance. The FDA classified it as Class II, and no injuries have been reported.
From the FDA notice · Read the official notice ↗
What to do
- Set aside affected vials and do not use them.
- Check the lot and expiry date on each carton. Affected lots are RPTL0325A (Dec 31, 2027), RPTL0425A (Dec 31, 2027), RPTL0624B (Nov 30, 2027), and RPTL0625A (Mar 31, 2028). The NDC is 70069-0834-01.
- The notice doesn't say how to get a refund or replacement. Contact Somerset Therapeutics, named on the carton, or the place you bought the product.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Pemetrexed for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0834-01
- Sold in
- Nationwide
This recall covers 4 products — see all of them.
Details
- Units affected
- 12,000 vials
- Manufactured in
- Ttc Area Of Midc, R - 282 Dhirubhai Ambani Life Sciences Centre; Thane Belapur Road, Navi Mumbai, N/A, India
- Classification
- Class II
- Recall number
- D-0671-2026
In the FDA's words
- Description
- Pemetrexed for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0834-01 Lack of Sterility Assurance Lot, expiry: RPTL0325A Dec 31, 2027; RPTL0425A Dec 31, 2027; RPTL0624B Nov 30,2027; RPTL0625A Mar 31, 2028 Distribution: Nationwide in the USA Affected quantity: 12,000 vials
- Hazard
- Lack of Sterility Assurance
4 products in this recall
Somerset Therapeutics cancer drug vials recalled for lack of sterility
Reliance Life Sciences is recalling four injectable cancer drugs made for Somerset Therapeutics: Pemetrexed for Injection 100 mg and 500 mg vials, Bortezomib for Injection 3.5 mg vials, and Azacitidine for Injection 100 mg vials. The recall covers about 36,000 vials nationwide because of a lack of sterility assurance. No injuries have been reported.
The agency lists each product separately. Check every one you might have.
- Pemetrexed for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC.,… (this page)D-0671-2026 · 12,000 vials
- Pemetrexed for Injection 500mg/Vial, 1 50 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC.,…D-0672-2026 · 5,020 vials
- Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: Somerset Therapeutics, LLC., Somerset…D-0673-2026 · 11,400 vials
- Azacitidine for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For Subcutaneous and Intravenous Use, Rx only, Manufactured for: Somerset Therap…D-0674-2026 · 8,001 vials